According to Joanna Bichsel, Kasha’s Founder and CEO: “It’s an exciting milestone for Kasha to partner so closely with Sanofi who is an important strategic partner for us. Over the years and across our countries of operations in Africa, Kasha has seen the fast growing demand for Non-Communicable Diseases (NCDs) like diabetes and hypertension. With this investment, we will scale up the awareness of NCDs and other health issues and make it easier and more affordable for people to get the medications they need, especially lower income and rural customers. Leveraging Kasha’s technology platform to drive access in a customer-driven and data-driven way, together Kasha and Sanofi can change the game in enabling full access to quality pharmaceuticals in Africa.”